CAS: 896705-16-1

BMH-21 is a molecule that binds to prostate cancer cells and blocks the surface glycoprotein, which leads to cell activation. BMH-21 also has an inhibitory effect on ribosome synthesis. It has been shown that prostate cancer cells are sensitive to BMH-21 treatment, with a predictive biomarker for the development of prostate cancer.

BMH-21

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.